(S)-iPr-MeOBIPHEP is widely used as a chiral ligand in asymmetric catalysis, particularly in hydrogenation reactions. It plays a crucial role in the synthesis of enantiomerically pure compounds, which are essential in the production of pharmaceuticals, agrochemicals, and fine chemicals. Its application in asymmetric hydrogenation helps in achieving high enantioselectivity and yield, making it valuable in the development of chiral intermediates for drugs and other bioactive molecules. Additionally, it is employed in academic and industrial research to explore new catalytic processes and improve the efficiency of existing synthetic routes.